NCT00635284View on ClinicalTrials.gov

ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

December 1, 2007

Primary Completion Date

June 1, 2011

Study Completion Date

June 1, 2011

Conditions

Solid Tumors

Interventions

DRUG

ABI-009

nab-rapamycin

Trial Locations (2)

77030

University of Texas M.D. Anderson Cancer Center, Houston

90403

Sarcoma Oncology Center, Santa Monica

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY

NCT00635284 - ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies | Biotech Hunter | Biotech Hunter